April 2012 Drug Information Update - Pharmacy Benefits ...
April 2012 Drug Information Update - Pharmacy Benefits ...
April 2012 Drug Information Update - Pharmacy Benefits ...
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
CODE<br />
Lot # 139961<br />
RECALLING FIRM/MANUFACTURER<br />
Bausch & Lomb, Inc., Tampa, FL, by letters on February 22, <strong>2012</strong>. Firm initiated recall is<br />
ongoing.<br />
REASON<br />
Impurity/Degradation; 9 month stability.<br />
PRODUCT (Class III)<br />
1) Squibb Kenalog Injection 10 (Triamcinolone Acetonide Injectable Suspension, USP), 50 mg/5<br />
mL, 10 mg/mL, 5 mL multiple vial, Rx only, NDC 0003-0494-20. Strength Product/SAP<br />
Package/I Description NDC Expiration No. 10 mg/mL KENALOG SINJ 10MG/ML<br />
(1VL.X5ML) US 0003-0494-20 SEPT <strong>2012</strong>. Recall # D-1269-<strong>2012</strong>;<br />
2) Squibb Kenalog Injection 40 (Triamcinolone Acetonide Injectable Suspension, USP), 40<br />
mg/mL, 10 mL multiple vial, Rx only, NDC 0003-0293-28, Strength Lot Number Product/SAP<br />
Package/I Description NDC Expiration No. 40 mg/mL KENALOG SINJ 40MG/ML<br />
(1VL.X5ML) US 0003-0293-20 SEPT <strong>2012</strong>,, 40 mg/mL KENALOG SINJ 40MG/ML<br />
(1VL.X10ML) US 0003-0293-28 OCT <strong>2012</strong>, 40 mg/mL KENALOG SINJ 40MG/ML<br />
(1VL.X10ML) US 0003-0293-28 OCT <strong>2012</strong>, 40 mg/mL KENALOG SINJ 40MG/ML<br />
(1VL.X10ML) US 0003-0293-28 OCT <strong>2012</strong>, 40mg/mL KENALOG SINJ 40MG/ML<br />
(1VLX10ML) US 0003-0293-28 OCT <strong>2012</strong>. Recall #D-1270-<strong>2012</strong><br />
CODE<br />
1) OK65465 1131273;<br />
2) OK66391 1131271; OK66412 1131272, OK66414 1131272, OK66501 1131272, OL56792<br />
1131272<br />
RECALLING FIRM/MANUFACTURER<br />
Bristol-Myers Squibb, Anagni, Italy, by letters dated October 21, 2011 and December 14, 2011.<br />
Firm initiated recall is ongoing.<br />
REASON<br />
Presence of Precipitate: Atypical particle size found in vial.<br />
PRODUCT (Class III)<br />
1) Enoxaparin Sodium Injection, USP, 100 mg/mL, 1 mL pre-filled Single Dose Syringe in a<br />
blister (NDC 0781-3500-05) packaged in 10-count Syringes in a blister per carton (NDC 0781-<br />
3500-69), Rx Only. Recall # D-1274-<strong>2012</strong>;<br />
2) Enoxaparin Sodium Injection, USP, 30 mg/0.3 mL, 0.3 mL pre-filled Single Dose Syringe in a<br />
blister, NDC 0781-3133-01, packaged in 10-count Syringes in a blister per carton, NDC 0781-<br />
3133-63, Rx Only. Recall # D-1275-<strong>2012</strong><br />
CODE<br />
1) Lot #: 917713, Exp 08/13;<br />
2) Lot #: 917995, Exp 08/13<br />
RECALLING FIRM/MANUFACTURER<br />
Recalling Firm: Sandoz Inc., Broomfield, CO, by letters on February 13, <strong>2012</strong>.<br />
Manufacturer: Baxter Pharmaceuticals Solutions, LLC, Bloomington, IN. Firm initiated recall is<br />
ongoing.<br />
REASON<br />
Defective Container: Small defects with stopper ribs.<br />
33